Error: Could not add to watchlist. X
+ Watchlist

Candriam Equities L Biotechnology

DEXEBTN:LX
345.72
USD
8.04
2.38%
As of 12:59 AM EDT 7/27/2016
Fund Type
SICAV
52Wk Range
284.80 - 469.26
1 Yr Return
-25.52%
YTD Return
-15.44%
Previous Close
337.68
52Wk Range
284.80 - 469.26
1 Yr Return
-26.15%
YTD Return
-15.44%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 07/27/2016)
345.72
Total Assets (m USD) (on 07/27/2016)
546.363
Inception Date
08/23/2002
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.00%
Expense Ratio
2.23%

Top Fund Holdings

Name Position Value % of Fund
150.50 k 43.60 m 8.06
262.00 k 41.38 m 7.65
427.00 k 37.17 m 6.87
324.00 k 34.19 m 6.32
82.50 k 32.91 m 6.08
264.00 k 22.28 m 4.12
234.00 k 20.98 m 3.88
121.00 k 18.26 m 3.37
180.00 k 11.16 m 2.06
119.50 k 11.13 m 2.06
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
Address
Candriam Luxembourg
136 route d'Arlon
1150 Luxembourg
Phone
352-254-3431